Thomas Ness

1.1k total citations
8 papers, 248 citations indexed

About

Thomas Ness is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Thomas Ness has authored 8 papers receiving a total of 248 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Thomas Ness's work include Pancreatic and Hepatic Oncology Research (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Epigenetics and DNA Methylation (2 papers). Thomas Ness is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Epigenetics and DNA Methylation (2 papers). Thomas Ness collaborates with scholars based in United Kingdom, Sweden and Germany. Thomas Ness's co-authors include W. Burnett, John C. Mathers, Jelena Mann, Quentin M. Anstee, Müjdat Zeybel, Timothy Hardy, Steve White, Stuart Robinson, Christopher P. Fox and Steven Masson and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Annals of the Rheumatic Diseases.

In The Last Decade

Thomas Ness

8 papers receiving 225 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Ness United Kingdom	5	123	63	58	53	44	8	248
Siddesh Besur United States	9	98 0.8×	48 0.8×	49 0.8×	163 3.1×	53 1.2×	15	361
Saba Kiremitçi Türkiye	10	52 0.4×	54 0.9×	57 1.0×	76 1.4×	47 1.1×	42	266
Laurence Britton Australia	10	162 1.3×	45 0.7×	71 1.2×	42 0.8×	18 0.4×	20	327
Tsukasa Kawaguchi Japan	8	201 1.6×	47 0.7×	83 1.4×	57 1.1×	37 0.8×	9	326
S. Fargion Italy	7	211 1.7×	66 1.0×	40 0.7×	35 0.7×	19 0.4×	12	480
Takeharu Asano Japan	8	99 0.8×	30 0.5×	124 2.1×	33 0.6×	74 1.7×	30	266
Sabine Fürst‐Recktenwald Switzerland	7	60 0.5×	75 1.2×	43 0.7×	73 1.4×	70 1.6×	12	278
David McDonald Australia	6	167 1.4×	71 1.1×	51 0.9×	15 0.3×	12 0.3×	14	299
F Duron France	10	75 0.6×	150 2.4×	64 1.1×	37 0.7×	15 0.3×	34	293

Countries citing papers authored by Thomas Ness

Since Specialization

Citations

This map shows the geographic impact of Thomas Ness's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Ness with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Ness more than expected).

Fields of papers citing papers by Thomas Ness

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Ness. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Ness. The network helps show where Thomas Ness may publish in the future.

Co-authorship network of co-authors of Thomas Ness

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Ness. A scholar is included among the top collaborators of Thomas Ness based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Ness. Thomas Ness is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Plummer, Ruth, Alastair Greystoke, Debashis Sarker, et al.. (2024). A Phase 1a/1b Study of Fostroxacitabine Bralpamide (Fostrox) Monotherapy in Hepatocellular Carcinoma and Solid Tumor Liver Metastases. Journal of Hepatocellular Carcinoma. Volume 11. 2033–2047. 2 indexed citations

2.

Reig, María, T.R. Jeffry Evans, Hong Jae Chon, et al.. (2024). First safety and efficacy data from phase Ib/IIa study of fostroxacitabine bralpamide (fostrox, MIV-818) in combination with lenvatinib in patients with hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 42(3_suppl). 476–476. 1 indexed citations

3.

Ding, Yuchun, et al.. (2022). An open source pipeline for quantitative immunohistochemistry image analysis of inflammatory skin disease using artificial intelligence. Journal of the European Academy of Dermatology and Venereology. 37(3). 605–614. 4 indexed citations

4.

Haugk, Beate, Kofi Oppong, John Leeds, et al.. (2021). Morphological and p40 immunohistochemical analysis of squamous differentiation in endoscopic ultrasound guided fine needle biopsies of pancreatic ductal adenocarcinoma. Scientific Reports. 11(1). 21290–21290. 2 indexed citations

5.

Zeybel, Müjdat, Timothy Hardy, Stuart Robinson, et al.. (2015). Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease. Clinical Epigenetics. 7(1). 25–25. 145 indexed citations

6.

Dejaco, Christian, Christina Duftner, Annette D. Wagner, et al.. (2013). NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica. Annals of the Rheumatic Diseases. 72(11). 1852–1859. 42 indexed citations

7.

Ness, Thomas & Wolfgang Paulus. (2010). Auge und Schwangerschaft. Der Ophthalmologe. 107(9). 863–873. 7 indexed citations

8.

Burnett, W. & Thomas Ness. (1955). Serum Amylase and Acute Abdominal Disease. BMJ. 2(4942). 770–772. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact